Compare Organon Pharma Indonesia Tbk. (SCPI) vs Tunas Baru Lampung Tbk. (TBLA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Tunas Baru Lampung Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Tunas Baru Lampung Tbk. trades at Rp625 (market cap 3.8T, 1.07M 24h volume). The key difference: Tunas Baru Lampung Tbk. is far larger — about 36.4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | TBLA | |
|---|---|---|
Market Cap | 104.4B | 3.8T |
Volume | — | 1.07M |
Lot | — | 10.69K |
Turnover | — | 664.27M |
Average Price | — | 621.51 |
Value | — | 664.27M |
Indicative Equilibrium Price | — | 625 |
Indicative Equilibrium Volume | — | 142 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Tunas Baru Lampung Tbk.
PT Tunas Baru Lampung Tbk (the Company) was established by virtue of Notarial Deed No. 23 dated December 22, 1973 of Halim Kurniawan, S.H., public notary in Teluk Betung. PT. Tunas Baru Lampung is a member of Sungai Budi Group which was founded in 1947 and is a pioneer in Indonesia`s agricultural industry.
Read more on TBLA →
